Wells Fargo & Company Abbott Laboratories Put Options Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $2.2 Million - $2.45 Million	21,800 Added 100.93%	43,400 $4.51 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $996,632 - $1.1 Million	-9,100 Reduced 29.64%	21,600 $2.46 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $1.8 Million - $2.21 Million	20,000 Added 186.92%	30,700 $3.38 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $219,719 - $263,626	-2,300 Reduced 17.69%	10,700 $1.04 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $2.03 Million - $2.26 Million	-20,100 Reduced 60.73%	13,000 $1.42 Million
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $1.65 Million - $1.94 Million	17,000 Added 105.59%	33,100 $3.35 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $76,048 - $89,216	800 Added 5.23%	16,100 $1.77 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $9,676 - $11,203	100 Added 0.66%	15,300 $1.48 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $1.55 Million - $1.87 Million	15,192 Added 189900.0%	15,200 $1.65 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $612 - $784	8 New	8 $2,000

3,136

1.33B

8.63M

7.17M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.